Bruce D. Hammock

Dr. Hammock is a Distinguished Professor at the University of California-Davis Comprehensive Cancer Center. He is a member of the National Academy of Sciences and the National Academy of Inventors. One of the most important aspects of Dr. Hammock’s scientific contributions is his discovery of the soluble epoxide hydrolase early in his career. Many of his over 1200 publications and patents are on the P450 branch of the arachidonic acid cascade and the role of soluble epoxide hydrolase in fatty acid metabolism. He continues as the founding Director of the multi-million dollar NIEHS-UCD Superfund Research Program now renewed through its 35th year. He was Principal Investigator of the NIH Biotechnology Graduate Training Program at the University of California Davis for over 15 years. Dr. Hammock has been the director of an analytical laboratory supporting a variety of NIH funded programs for 20 years. He is a past NIH Career and Merit Awardee; a Burroughs Wellcome Scholar; and a von Humboldt, Marcus and Fulbright Fellow. He recently was selected for the Brodie Award in Xenobiotic Metabolism, the Lands Lecture in Biochemical Nutrition, and as the first McGiff Memorial Awardee in Lipid Biochemistry. He founded several companies, has helped raise over $50 million in private capital and currently is CEO of EicOsis developing an orally active non-addictive drug for inflammatory and neuropathic pain in man and companion animals. EicOsis is supported by several SBIR grants and a NIH NINDS Blueprint Development Grant.